2018 journal article

Combination of blood and biphasic calcium phosphate microparticles for the reconstruction of large bone defects in dog: A pilot study

Journal of Biomedical Materials Research Part A, 106(7), 1842–1850.

By: T. Balaguer*, B. Fellah, F. Boukhechba*, M. Traverson*, X. Mouska*, D. Ambrosetti*, B. Dadone*, J. Michiels* ...

co-author countries: France 🇫🇷
author keywords: biphasic calcium phosphate; blood; critical bone defects; autologous bone graft; dog
MeSH headings : Animals; Blood / metabolism; Bone Regeneration / drug effects; Bone and Bones / drug effects; Bone and Bones / pathology; Calcium Phosphates / pharmacology; Dogs; Femur / diagnostic imaging; Femur / drug effects; Femur / pathology; Implants, Experimental; Microspheres; Osteogenesis / drug effects; Pilot Projects; Ulna / diagnostic imaging; Ulna / drug effects; Ulna / pathology; X-Ray Microtomography
Source: Crossref
Added: July 20, 2019

We previously reported that biphasic calcium phosphate (BCP) microparticles embedded in a blood clot induces ectopic bone formation in mice and repairs a critical femoral defect in rat. The present pilot study aimed to evaluate in dog and in two models of large defects the efficacy of this composite named "blood for reconstruction of bone" (BRB). We show here that BRB is a cohesive biomaterial easy to prepare from dog autologous blood and to mold to fill large bone defects. First in a model of cylindrical femoral condyle defect, the BRB was compared with BCP particles alone. After 8 weeks, this revealed that the amount of mature bone was slightly and significantly higher with BRB than with BCP particles. Second, in a model consisting in a 2 cm-long critical interruptive defect of the ulna, the BRB was compared with autologous bone. After 6 months, we observed that implantation of BRB can induce the complete reconstruction of the defect and that newly formed bone exhibits high regenerative potential. Comparison with the results obtained with autologous bone grafting strongly suggests that the BRB might be an efficient biomaterial to repair large bone defects, as an alternative or in addition to autologous bone. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 1842-1850, 2018.